We are committed to building a comprehensive product portfolio mainly targeting two markets with large unmet demands, namely vascular intervention, and NOTES.
We have been concurrently developing cryotherapy systems for treating atrial fibrillation, hypertension, ladder cancer, chronic obstructive pulmonary disease, airway stenosis, asthma, and other diseases. In parallel we have developed non-cryotherapy products including our endoscopic clip for anastomosis and anti-gastroesophageal reflux system. Furthermore, we have successfully commercialized certain minimally invasive surgical consumables, such as the pulmonary nodule localization needle and laparoscopic single-port multi-channel access platform.
Invest in vascular intervention to develop innovative cryoablation systems for treatments of serious diseases such as atrial fibrillation and hypertension. Provide clinical solutions to fulfill a variety of unmet clinical needs through NOTES